Iterum Therapeutics plc (ITRM)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
At close: 03:59PM EST
After hours:
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 17.13M |
| Enterprise Value | -17.01M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.53 |
| Enterprise Value/Revenue | 105.22 |
| Enterprise Value/EBITDA | 0.46 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.41 |
| 52-Week Change 3 | -76.19% |
| S&P500 52-Week Change 3 | -7.13% |
| 52 Week High 3 | 7.0500 |
| 52 Week Low 3 | 0.6010 |
| 50-Day Moving Average 3 | 1.1381 |
| 200-Day Moving Average 3 | 2.4427 |
Share Statistics
| Avg Vol (3 month) 3 | 372.49k |
| Avg Vol (10 day) 3 | 91.54k |
| Shares Outstanding 5 | 12.23M |
| Implied Shares Outstanding 6 | N/A |
| Float 8 | 12.14M |
| % Held by Insiders 1 | 0.73% |
| % Held by Institutions 1 | 2.69% |
| Shares Short (Jan 12, 2023) 4 | 355.29k |
| Short Ratio (Jan 12, 2023) 4 | 0.38 |
| Short % of Float (Jan 12, 2023) 4 | 2.94% |
| Short % of Shares Outstanding (Jan 12, 2023) 4 | 2.90% |
| Shares Short (prior month Dec 14, 2022) 4 | 139.85k |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | N/A |
| Last Split Factor 2 | 1:15 |
| Last Split Date 3 | Aug 17, 2022 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | Dec 30, 2021 |
| Most Recent Quarter (mrq) | Sept 29, 2022 |
Profitability
| Profit Margin | 0.00% |
| Operating Margin (ttm) | 0.00% |
Management Effectiveness
| Return on Assets (ttm) | -21.54% |
| Return on Equity (ttm) | -102.42% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -26.15M |
| Net Income Avi to Common (ttm) | -43.53M |
| Diluted EPS (ttm) | 0.1300 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 64.36M |
| Total Cash Per Share (mrq) | 5.26 |
| Total Debt (mrq) | 31.8M |
| Total Debt/Equity (mrq) | 97.71 |
| Current Ratio (mrq) | 8.88 |
| Book Value Per Share (mrq) | 2.66 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -16.67M |
| Levered Free Cash Flow (ttm) | -14.93M |
© 2023 Yahoo. All rights reserved.
